| 81 |
Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? |
2020 |
| 82 |
Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center |
2020 |
| 83 |
Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center |
2020 |
| 84 |
Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center |
2020 |
| 85 |
Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer |
2020 |
| 86 |
Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer |
2020 |
| 87 |
Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer |
2020 |
| 88 |
Right and Left Colon Cancer: Clinico-Pathological Features and Treatment Results (South Egypt
Cancer Institute Experience) |
2020 |
| 89 |
Right and Left Colon Cancer: Clinico-Pathological Features and Treatment Results (South Egypt
Cancer Institute Experience) |
2020 |
| 90 |
Right and Left Colon Cancer: Clinico-Pathological Features and Treatment Results (South Egypt
Cancer Institute Experience) |
2020 |
